Prasad’s short FDA tenure brought stricter review standards for gene and COVID vaccines, sparking biotech concern and political backlash.

The motivation is solely what we think is in the public interest— the accurate judgment of benefits and risks,” Prasad wrote.

Vinay Prasad overruled other reviewers for a third time in recent months in clearing only narrow use of Moderna's vaccine in ...

Vinay Prasad, the top vaccine regulator and chief scientific officer at the Food and Drug Administration (FDA) and a critic of the agency’s COVID-19 policies, has departed after being on the job ...

The Food and Drug Administration (FDA) has tapped Vinay Prasad, a prominent critic of federal COVID-19 policies and a proponent of more stringent approval standards, to lead the agency’s ...

Vinay Prasad, MD, MPH, a frequent critic of the FDA and COVID-19 lockdowns and vaccination policies, will be the next director of FDA's Center for Biologics Evaluation and Research (CBER), the ...

The new documents offer a window into Dr. Prasad’s vision for the agency and his thinking on vaccine policy. The records reveal that F.D.A. staff members concluded that the vaccines were safe ...

Prasad, like Makary, has a link to Brownstone and spent years criticizing the FDA over Covid jabs, hyping up safety concerns about rare side effects like myocarditis, questioning their efficacy ...

Makary and Prasad co-authored a paper in 2022 in the British Medical Journal, finding that COVID-19 booster mandates for teenagers and young adults did more harm than good, particularly causing ...

FDA lays out stricter COVID vaccine policy in pivot from 'one-size-fits-all' approach By Zoey Becker May 20, 2025 1:20pm Martin Makary Vinay Prasad FDA COVID-19 ...